NovAb
Tucker, US · Founded 2013 · Georgia corporation
Founders & leadership
LE
Lovick Edward CannonNamed on SEC filing
MD
Max D. CooperNamed on SEC filing
Board
TC
Thomas Chris CannonBoard director
GD
Gregory DaneBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 8 of 9 rounds · 2016–2026
▶$65KraisedApr 2026 · 2 investors · BiotechnologyRule 506(b)
▶$65KraisedApr 2026 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory DaneDirector
- Lovick Edward CannonExecutive Officer, Director
- Thomas Chris CannonDirector
- Offering amount
- $250K
- Amount sold
- $65K
- First sale
- Apr 2026
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
▶$50KraisedJan 2026 · 2 investors · BiotechnologyRule 506(b)
▶$50KraisedJan 2026 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas Chris CannonDirector
- Lovick Edward CannonExecutive Officer, Director
- Gregory DaneDirector
- Offering amount
- $50K
- Amount sold
- $50K
- First sale
- Jan 2026
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
▶$210KraisedAug 2025 · 2 investors · BiotechnologyRule 506(b)
▶$210KraisedAug 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory DaneDirector
- Thomas Chris CannonDirector
- Lovick Edward CannonExecutive Officer, Director
- Offering amount
- $210K
- Amount sold
- $210K
- First sale
- Jul 2025
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
▶$250KraisedFeb 2025 · 3 investors · BiotechnologyRule 506(b)
▶$250KraisedFeb 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas Chris CannonDirector
- Gregory DaneDirector
- Lovick Edward CannonExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Jan 2025
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
▶$125KraisedJul 2024 · 2 investors · BiotechnologyRule 506(b)
▶$125KraisedJul 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lovick Edward CannonExecutive Officer, Director
- Thomas Chris CannonDirector
- Gregory DaneDirector
- Offering amount
- $125K
- Amount sold
- $125K
- First sale
- Jun 2024
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
▶$250KraisedAug 2023 · 3 investors · BiotechnologyRule 506(b)
▶$250KraisedAug 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory DaneDirector
- Lovick Edward CannonExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $250K
- First sale
- Jul 2023
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
▶$300KraisedMar 2023 · 3 investors · BiotechnologyRule 506(b)
▶$300KraisedMar 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lovick Edward CannonExecutive Officer, Director
- Gregory DaneDirector
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- Feb 2023
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
▶$300KraisedMar 2022 · 5 investors · BiotechnologyRule 506(b)
▶$300KraisedMar 2022 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory DaneDirector
- Lovick Edward CannonExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $300K
- First sale
- Mar 2022
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has NovAb raised?
- NovAb has disclosed $1.6M raised across 8 of its 9 known rounds.
- Where is NovAb headquartered?
- NovAb is headquartered in Tucker, US.